Embecta Corp

STU:JX7 (USA)  
€ 19.00 (0%) Dec 20
Market Cap:
€ 1.14B ($ 1.18B)
Enterprise V:
€ 2.42B ($ 2.53B)
Volume:
-
Avg Vol (2M):
146.00
Trade In:

Business Description

Description
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.17
Equity-to-Asset -0.57
Debt-to-Equity -2.18
Debt-to-EBITDA 8.35
Interest Coverage 2.54
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.44
Distress
Grey
Safe
Beneish M-Score -1.21
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 66.97
9-Day RSI 66.84
14-Day RSI 66.9
6-1 Month Momentum % 9.4
12-1 Month Momentum % -20.99

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.03
Quick Ratio 1.58
Cash Ratio 0.72
Days Inventory 152.74
Days Sales Outstanding 39.08
Days Payable 57.59

Financials (Next Earnings Date:2025-02-07 Est.)

STU:JX7's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Embecta Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 1,029.437
EPS (TTM) (€) 1.238
Beta 0
Volatility % 70.01
14-Day RSI 66.9
14-Day ATR (€) 0.442339
20-Day SMA (€) 18.3
12-1 Month Momentum % -20.99
52-Week Range (€) 9.35 - 19.8
Shares Outstanding (Mil) 58.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Embecta Corp Filings

Filing Date Document Date Form
No Filing Data

Embecta Corp Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Embecta Corp Frequently Asked Questions

What is Embecta Corp(STU:JX7)'s stock price today?
The current price of STU:JX7 is €19.00. The 52 week high of STU:JX7 is €19.80 and 52 week low is €9.35.
When is next earnings date of Embecta Corp(STU:JX7)?
The next earnings date of Embecta Corp(STU:JX7) is 2025-02-07 Est..
Does Embecta Corp(STU:JX7) pay dividends? If so, how much?
The  Dividend Yield %  of Embecta Corp(STU:JX7) is 2.85% (As of Today), Highest Dividend Payout Ratio of Embecta Corp(STU:JX7) was 0.27. The lowest was 0.03. And the median was 0.2. The  Forward Dividend Yield % of Embecta Corp(STU:JX7) is 2.93%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release